Overview
- Multiple investor law firms, including Hagens Berman, Rosen, Bernstein Liebhard, Bragar Eagel & Squire, Faruqi & Faruqi, and Kahn Swick & Foti, are urging shareholders to seek lead‑plaintiff status before the October 10, 2025 deadline.
- The securities class action, Pahlkotter v. SelectQuote, Inc., is pending in the Southern District of New York and covers purchasers of SelectQuote stock from September 9, 2020 through May 1, 2025.
- On May 1, 2025, the Department of Justice filed a False Claims Act complaint alleging SelectQuote received tens of millions of dollars in illegal payments from 2016 through at least 2021 to influence Medicare plan enrollments.
- The DOJ alleges SelectQuote misrepresented offering unbiased comparisons while steering beneficiaries to higher‑commission plans and participating in discriminatory practices against less‑profitable enrollees, including people with disabilities.
- SelectQuote shares fell 19.2% to close at $2.56 on May 1, 2025 following the DOJ filing, and plaintiff firms are also inviting whistleblowers with nonpublic information to come forward.